A member of
The company Johnson&Johnson announced its proposal to acquire Actelion via a takeover offer to the shareholders of Johnson&Johnson at a price of USD 280.00 plus one New R&D-Company-Share per share.
More information about this transaction is available on the company`s website under www.actelion.com.
This information describes the potential effects this transaction will have on the above mentioned contracts.
Frankfurt, 24.03.2017:
The company Johnson&Johnson announced its proposal to acquire Actelion via a takeover offer to the shareholders of Johnson&Johnson at a price of USD 280.00 plus one New R&D-Company-Share per share.
On 16 February 2017 the offer prospectus was published. According to the indicative schedule, the main offer period ends on 30 March 2017, subject to any prolongation. After the main Offer Period and if the Offer is declared as successful, there will be an additional acceptance period, which is expected to end on 21 April 2017. Tendered shares will be trading as a second line under a separate ISIN. It is expected that trading on the second line will be terminated upon the expiration of the Additional Acceptance Period or, in the event of a Postponement, on the second Trading Day prior to the Settlement Date. Where required, the existing Eurex contracts may be switched to the tendered line of shares. We will inform in due time if, and when such a switch will be done. Should the Offer be successful and if the conditions for the settlement of the Eurex contracts are met, the final settlement of the contracts will take place based on the Offer Price of US Dollar 280.00 plus the value of the R&D NewCo-share. According to the Offer Prospectus, the R&D New Co-shares will be listed on the completion day of the Offer on SIX.
Total Offer Price = 280.00 US Dollar (recalculation into CHF-value is done based on the Euro foreign exchange reference rates) + Opening price of R&D Newco share on SIX
We will keep you informed about the further procedure whenever changes or new information in the course of the transaction render this necessary.
Frankfurt: 31.03.2017
On 31 March 2017 Actelion Ltd. announced via media release, that Johnson & Johnson declared the tender offer as successful after the closing of the initial acceptance period. The additional acceptance period will commence on 6 April 2017 and will end on 21 April 2017. As already announced in the corporate action info 002, the Eurex contracts will switch to the tendered shares until completion of the offer. The conversion will become effective with the start of the additional acceptance period on 6 April 2017. Further information with respect to the settlement of the contracts will be published as soon as Johnson & Johnson will announce the exact schedule for the completion of the offer.
|
Frankfurt, 02.05.2017
On 27 April 2017, Johnson + Johnson and Actelion Ltd announced the definitive notice of the end result of the public takeover to the shareholders of Actelion Ltd. According to the notice, the settlement of the Offer has been postponed until the satisfaction of certain Offer conditions. The companies will announce the settlement day of the Offer after the satisfaction of the remaining Offer conditions.
Settlement of the Eurex contracts is scheduled to take place on the settlement day with effect as of the following exchange-trading day. As already described in corporate action info 002, settlement will be done based on the offer price plus the value of the R&D NewCo-share. According to the offer prospectus, the R&D NewCo shares will be listed on the settlement day of the Offer on SIX Swiss Exchange.
Total Offer Price = 280.00 US Dollar (recalculation into CHF-value is done based on the ECB Euro foreign exchange reference rates) + Opening price of R&D NewCo share on SIX Swiss Exchange.
Trading in the Eurex contracts will be halted immediately after the announcement of the settlement day, latest with the discontinuation of trading of the Actelion-shares tendered into the offer.
On 09 June 2017, Johnson + Johnson announced the expected settlement date of the public takeover to the shareholders of Actelion Ltd. According to the notice, the settlement of the Offer is scheduled for 16 June 2017. This is also the listing date of the Idorsia-shares on the SIX Swiss Exchange.
Settlement of the Eurex contracts is also scheduled to take place on the settlement day with effect as of the following exchange-trading day. As already described in corporate action info 002, settlement will be done based on the offer price plus the value of the Idorsia-share.
Total Offer Price = 280.00 US Dollar (recalculation into CHF-value is done based on the ECB Euro foreign exchange reference rates) + Opening price of Idorsia share on SIX Swiss Exchange.
Trading in the Eurex contracts will be discontinued with the delisting of the Actelion-shares tendered into the offer after close of trading on 13 June 2017. This is also the last day on which an exercise of the option contract is possible. The settlement details will be published on the expected settlement day (16 June 2017).
Result:
Johnson & Johnson today announced the completion of the takeover of Actelion Ltd. Accordingly, as described in Corporate Action announcements 001-006 and pursuant to the Contract Specifications for Futures Contracts and Options Contracts at Eurex Deutschland and Eurex Zürich, number 1.6.7 (7) and 2.6.10.1 (7) existing positions in the series for the Eurex option contract and Future contract on shares of Actelion Ltd will be settled at the theoretical fair value. The theoretical fair value is based on the total Offer price which is calculated as follows:
Total Offer price = CHF 272,93 (USD 280.00 converted to CHF) + Opening price of Idorsia shares CHF 10.00 = CHF 282.93
Settlement of the options contract will take place based on the settlement prices of 16 June 2017.
On 16 June 2017, all participants with open positions will receive a FAX containing an overview of their respective open positions. Booking of the cash amount will take place on 16 June 2017 with value date 19 June 2017. All positions will be transferred and booked out on 16 June 2017.
For a list of theoretical fair values (final settlement prices) for the respective series of the Eurex option contract on shares of Actelion Ltd, please refer to the attachment.
| Contract | Settlement Price | U/L ClsPrc |
| C ATLN JUN17 9200 | 190,93 | 282,93 |
| C ATLN JUN17 10000 | 182,93 | 282,93 |
| C ATLN JUN17 12000 | 162,93 | 282,93 |
| C ATLN JUN17 13000 | 152,93 | 282,93 |
| C ATLN JUN17 14000 | 142,93 | 282,93 |
| C ATLN JUN17 15000 | 132,93 | 282,93 |
| C ATLN JUN17 16000 | 122,93 | 282,93 |
| C ATLN JUN17 17000 | 112,93 | 282,93 |
| C ATLN JUN17 18000 | 102,93 | 282,93 |
| C ATLN JUN17 19000 | 92,93 | 282,93 |
| C ATLN JUN17 20000 | 82,93 | 282,93 |
| C ATLN JUN17 22000 | 62,93 | 282,93 |
| C ATLN JUN17 24000 | 42,93 | 282,93 |
| C ATLN JUN17 26000 | 22,93 | 282,93 |
| C ATLN JUN17 27000 | 12,93 | 282,93 |
| C ATLN JUN17 28000 | 2,93 | 282,93 |
| C ATLN SEP17 12000 | 162,93 | 282,93 |
| C ATLN SEP17 13000 | 152,93 | 282,93 |
| C ATLN SEP17 14000 | 142,93 | 282,93 |
| C ATLN SEP17 15000 | 132,93 | 282,93 |
| C ATLN SEP17 16000 | 122,93 | 282,93 |
| C ATLN SEP17 17000 | 112,95 | 282,93 |
| C ATLN SEP17 18000 | 103,02 | 282,93 |
| C ATLN SEP17 19000 | 93,17 | 282,93 |
| C ATLN SEP17 20000 | 83,46 | 282,93 |
| C ATLN SEP17 22000 | 64,78 | 282,93 |
| C ATLN SEP17 24000 | 47,64 | 282,93 |
| C ATLN SEP17 26000 | 33,12 | 282,93 |
| C ATLN SEP17 28000 | 21,54 | 282,93 |
| C ATLN SEP17 36000 | 2,20 | 282,93 |
| C ATLN DEC17 8400 | 198,93 | 282,93 |
| C ATLN DEC17 9200 | 190,93 | 282,93 |
| C ATLN DEC17 10000 | 182,93 | 282,93 |
| C ATLN DEC17 12000 | 162,93 | 282,93 |
| C ATLN DEC17 14000 | 142,96 | 282,93 |
| C ATLN DEC17 16000 | 123,15 | 282,93 |
| C ATLN DEC17 18000 | 103,73 | 282,93 |
| C ATLN DEC17 20000 | 85,09 | 282,93 |
| C ATLN DEC17 22000 | 67,67 | 282,93 |
| C ATLN DEC17 24000 | 52,01 | 282,93 |
| C ATLN DEC17 26000 | 38,61 | 282,93 |
| C ATLN DEC17 28000 | 27,75 | 282,93 |
| C ATLN DEC17 32000 | 13,13 | 282,93 |
| C ATLN JUN18 9200 | 190,93 | 282,93 |
| C ATLN JUN18 14000 | 143,27 | 282,93 |
| C ATLN JUN18 16000 | 124,02 | 282,93 |
| C ATLN JUN18 20000 | 88,10 | 282,93 |
| C ATLN JUN18 24000 | 57,72 | 282,93 |
| C ATLN JUN18 28000 | 35,23 | 282,93 |
| C ATLN JUN18 32000 | 20,26 | 282,93 |
| C ATLN DEC18 14000 | 143,56 | 282,93 |
| C ATLN DEC18 16000 | 124,75 | 282,93 |
| C ATLN DEC18 18000 | 106,89 | 282,93 |
| C ATLN DEC18 20000 | 90,47 | 282,93 |
| C ATLN DEC18 24000 | 61,76 | 282,93 |
| C ATLN DEC18 28000 | 39,87 | 282,93 |
| P ATLN JUN17 9200 | 0,00 | 282,93 |
| P ATLN JUN17 10000 | 0,00 | 282,93 |
| P ATLN JUN17 12000 | 0,00 | 282,93 |
| P ATLN JUN17 13000 | 0,00 | 282,93 |
| P ATLN JUN17 14000 | 0,00 | 282,93 |
| P ATLN JUN17 15000 | 0,00 | 282,93 |
| P ATLN JUN17 16000 | 0,00 | 282,93 |
| P ATLN JUN17 17000 | 0,00 | 282,93 |
| P ATLN JUN17 18000 | 0,00 | 282,93 |
| P ATLN JUN17 19000 | 0,00 | 282,93 |
| P ATLN JUN17 20000 | 0,00 | 282,93 |
| P ATLN JUN17 22000 | 0,00 | 282,93 |
| P ATLN JUN17 24000 | 0,00 | 282,93 |
| P ATLN JUN17 26000 | 0,00 | 282,93 |
| P ATLN JUN17 27000 | 0,00 | 282,93 |
| P ATLN JUN17 28000 | 0,00 | 282,93 |
| P ATLN SEP17 12000 | 0,01 | 282,93 |
| P ATLN SEP17 13000 | 0,01 | 282,93 |
| P ATLN SEP17 14000 | 0,01 | 282,93 |
| P ATLN SEP17 15000 | 0,03 | 282,93 |
| P ATLN SEP17 16000 | 0,06 | 282,93 |
| P ATLN SEP17 17000 | 0,13 | 282,93 |
| P ATLN SEP17 18000 | 0,23 | 282,93 |
| P ATLN SEP17 19000 | 0,42 | 282,93 |
| P ATLN SEP17 20000 | 0,75 | 282,93 |
| P ATLN SEP17 22000 | 2,15 | 282,93 |
| P ATLN SEP17 24000 | 5,08 | 282,93 |
| P ATLN SEP17 26000 | 10,62 | 282,93 |
| P ATLN SEP17 28000 | 19,09 | 282,93 |
| P ATLN SEP17 36000 | 79,93 | 282,93 |
| P ATLN DEC17 8400 | 0,01 | 282,93 |
| P ATLN DEC17 9200 | 0,02 | 282,93 |
| P ATLN DEC17 10000 | 0,03 | 282,93 |
| P ATLN DEC17 12000 | 0,08 | 282,93 |
| P ATLN DEC17 14000 | 0,20 | 282,93 |
| P ATLN DEC17 16000 | 0,51 | 282,93 |
| P ATLN DEC17 18000 | 1,22 | 282,93 |
| P ATLN DEC17 20000 | 2,71 | 282,93 |
| P ATLN DEC17 22000 | 5,42 | 282,93 |
| P ATLN DEC17 24000 | 9,87 | 282,93 |
| P ATLN DEC17 26000 | 16,57 | 282,93 |
| P ATLN DEC17 28000 | 25,82 | 282,93 |
| P ATLN DEC17 32000 | 51,38 | 282,93 |
| P ATLN JUN18 9200 | 0,11 | 282,93 |
| P ATLN JUN18 14000 | 0,98 | 282,93 |
| P ATLN JUN18 16000 | 2,03 | 282,93 |
| P ATLN JUN18 20000 | 6,76 | 282,93 |
| P ATLN JUN18 24000 | 17,02 | 282,93 |
| P ATLN JUN18 28000 | 35,08 | 282,93 |
| P ATLN JUN18 32000 | 60,62 | 282,93 |
| P ATLN DEC18 14000 | 1,81 | 282,93 |
| P ATLN DEC18 16000 | 3,48 | 282,93 |
| P ATLN DEC18 18000 | 6,07 | 282,93 |
| P ATLN DEC18 20000 | 10,10 | 282,93 |
| P ATLN DEC18 24000 | 22,19 | 282,93 |
| P ATLN DEC18 28000 | 40,94 | 282,93 |
Futures
There are no open positions in ATLH
Market Status ⓘ
XEUR
The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.
Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message.
We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.
An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.